CORPORATE INFO
FOR INVESTORS
OUR PRODUCTS
BUSINESS DEVELOPMENT
CONTACT US
HOME
Menu
Financial Statements
Financial Reports
Securities Filing
Investor Resources
Fact Sheet
Presentations
Analyst Coverage
Calendar of Events
FAQ
Shareholder
Services
Investor Kit
Investor Information
News
Press Releases
Corporate News
Awards
PRESS RELEASES
COMMUNIQUÉS DE PRESSE (Français)
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
2006
|
2005
|
2004
|
2003
|
2002
|
2001
|
2000
|
1999
|
1998
|
1997
|
May 16, 2013
PALADIN LABS TO PRESENT AT THE BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE IN TORONTO
(Also in
PDF
format)
May 9, 2013
CORRECTION FROM SOURCE/PALADIN LABS REPORTS FIRST QUARTER 2013 RESULTS: ACHIEVES RECORD REVENUES
(Also in
PDF
format)
May 9, 2013
PALADIN LABS REPORTS FIRST QUARTER 2013 RESULTS: ACHIEVES RECORD REVENUES
(Also in
PDF
format)
May 2, 2013
NOTICE OF PALADIN LABS' FIRST QUARTER 2013 RESULTS CONFERENCE CALL
(Also in
PDF
format)
May 1, 2013
PALADIN LABS ANNOUNCES THE CANADIAN LAUNCH OF SILENOR(R)
(Also in
PDF
format)
April 24, 2013
PALADIN LABS ANNOUNCES THE CANADIAN LAUNCH OF AMNIOSENSE(TM)
(Also in
PDF
format)
March 5, 2013
PALADIN LABS ANNOUNCES THE CANADIAN LAUNCH OF VAGISENSE(TM)
(Also in
PDF
format)
February 28, 2013
PALADIN ANNOUNCES NORMAL COURSE ISSUER BID AND AUTOMATIC SHARE PURCHASE PLAN
(Also in
PDF
format)
February 28, 2013
PALADIN REPORTS RECORD 2012 RESULTS
(Also in
PDF
format)
February 21, 2013
NOTICE OF PALADIN LABS' 2012 RESULTS CONFERENCE CALL
(Also in
PDF
format)
January 16, 2013
PALADIN LABS SIGNS AGREEMENT FOR NOVEL BIOLOGIC TO TREAT NEUROBLASTOMA
(Also in
PDF
format)
January 14, 2013
PALADIN LABS ANNOUNCES CLOSING OF STRATEGIC PARTNERSHIP WITH ATIVA
(Also in
PDF
format)
January 8, 2013
PALADIN LABS ACQUIRES DISTRIBUTION RIGHTS TO POLLINEX(R)-R IN CANADA
(Also in
PDF
format)
HOME
|
SITE MAP
|
LEGAL DISCLAIMER
